Search results for " growth"
Article
Quality by design for biotechnology products—part 1
For the reactor expansion unit operation, for example, the cell growth, viable cell density, culture viability, and glucose concentration may be affected by the inoculum, medium, bioreactor operation,…
Article
Boosting biopharma resilience: The need to shift focus and increase collaboration
The 2023 Global Biopharma Resilience Index from Cytiva offers insights into the current state of the industry, shining a light on both areas of strength and opportunities for collaborative growth. By …
Article
A scalable single-use two-step plasmid purification process
The current global demand for biopharmaceuticals is over USD 300 billion, with an estimated growth of ≥ 12% annually. While MAb processes have become much more efficient, production of mRN…
Article
High-concentration monoclonal antibody drugs: manufacturing challenges
The growth in the formulation of drugs suitable for delivery by subcutaneous (Sub-C) injection highlights manufacturing challenges associated with the higher concentration of active ingredient…
Article
Optimizing your Cell Culture Process to Improve Productivity
Our cells utilize different components during their growth and productivity cycles—it is good to understand the level of those components. You can use it to characterize subculture system parameters f…
Webcast
Bioprocessing Europe – 14-16 March 2023
…nd is regarded by many as “the fastest growing bioprocessing meeting in Europe” following record growth in 2022 – 350 to 500+ attendees - and a sold out Exhibit Hall.
Article
Designing a 1.5 L Bench-Scale Model of a Perfusion Process
Establishing an appropriate model allows for higher throughput during simultaneous operation and monitoring of several cultures at different process conditions. In this article, we discus…
Article
Cytiva and Pall Corporation Investing 1.5 Billion USD Over Two Years to Meet Growing Demand for Biotechnology Solutions
Click here to read more >>
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services acros…
Article
Akron Bio Will Install a Cytiva FlexFactory to Manufacture Plasmid DNA
“With the accelerated growth of the biotechnology industry, companies must choose technologies and solutions that can quickly scale to meet future needs. Cytiva’s FlexFactory provides the speed and fl…
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The company will also hire nearly 1000 personnel in key areas as part of its strategy to support long-term growth in the biotechnology industry.
The investment will include new manufacturing lines …